Quest Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.97M Hold
7,824
0.23% 63
2026
Q1
$1.7M Buy
+7,824
New +$1.74M 0.2% 65
2015
Q4
Sell
-7,210
Closed -$392K 107
2015
Q3
$392K Buy
7,210
+425
+6% +$27.7K 0.05% 91
2015
Q2
$456K Sell
6,785
-900
-12% -$58.8K 0.06% 90
2015
Q1
$450K Buy
7,685
+345
+5% +$20.8K 0.06% 102
2014
Q4
$480K Sell
7,340
-385
-5% -$24.3K 0.06% 101
2014
Q3
$446K Hold
7,725
0.05% 132
2014
Q2
$436K Buy
7,725
+1,145
+17% +$60.1K 0.04% 141
2014
Q1
$338K Buy
6,580
+1,040
+19% +$52.6K 0.03% 171
2013
Q4
$293K Buy
5,540
+400
+8% +$19.7K 0.03% 184
2013
Q3
$230K Sell
5,140
-550,158
-99% -$24.4M 0.02% 196
2013
Q2
$23M Buy
+555,298
New +$24.3M 1.74% 13

Other funds holding ABBV

Quest Investment Management's ABBV Position: Q2 2026 in Review

Quest Investment Management held its AbbVie (ABBV) position steady in Q2 2026 at 7,824 shares worth $1.97M. The position accounts for 0.23% of the portfolio, ranked #63.

Quest Investment Management first reported a position in ABBV in Q2 2013 and has held it in 12 quarters since. The position peaked at $23M in Q2 2013. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Quest Investment Management held 7,824 shares of AbbVie worth $1.97M as of Q2 2026.
  • Quest Investment Management left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.23% of Quest Investment Management's portfolio in Q2 2026, its #63 holding.
  • Quest Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 12 quarters since.
  • Quest Investment Management's AbbVie position peaked at $23M in Q2 2013.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Quest Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.